-20℃ 3 years powder
-80℃ 2 years in solvent
PF-06869206 is an oral selective inhibitor of the sodium-phosphate cotransporter NaPi2a (SLC34A1, IC50: 380 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | 68.00 | |
10 mg | Inquiry | 113.00 | |
25 mg | Inquiry | 239.00 | |
50 mg | Inquiry | 410.00 | |
100 mg | Inquiry | 707.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | 57.00 |
Description | PF-06869206 is an oral selective inhibitor of the sodium-phosphate cotransporter NaPi2a (SLC34A1, IC50: 380 nM). |
Targets&IC50 | |
In vivo | In rodent PK, PF-06869206 show moderate clearance in both rat and mouse. Oral bioavailability at 5 mg/kg is good in rat and moderate in mouse. At higher oral doses of 50 mg/kg, supraproportional increases in exposure are observed in both species, suggestive of saturation of clearance. PF-06869206 has moderate terminal elimination half-life (t1/2=1.35 h, and 0.75 h for Wistar-Han rats (10 mg/kg, iv), and C57BL6 mice (1 mg/kg, iv)). |
Animal Research |
Male Wistar-Han rats are treated with PF-06869206 (1 mg/kg, 5 mg/kg, and 50 mg/kg; 2 mL/kg for iv or 10 mL/kg for po) . C57BL6 mice are treated with PF-06869206 (1 mg/kg, 5 mg/kg, and 50 mg/kg; 2 mL/kg for iv or 10 mL/kg for po).
|
Appearance | solid |
Molecular Weight | 374.75 |
Formula | C15H14ClF3N4O2 |
CAS No. | 2227425-05-8 |
-20℃ 3 years powder
-80℃ 2 years in solvent
:
DMSO: 120 mg/mL (320.22 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.